CD226 and gastric cancer: We found that the GC patients with a higher ratio of CD8+CD226+TILs among total CD8+TILs favored better OS than those with a lower ratio (HR=0.5347, 95% CI: 0.3244-0.8815, P=0.0067, Figure 3D).